Michael A. Lawless
Michael A. Lawless's purchase track record
Michael A. Lawless has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/23/2024 | LFWD | $10K | -29.7% | -62.7% | +12.9% |
| 8/23/2023 | LFWD | $9K | +23.2% | +47.8% | +12.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
LFWD CFO Succession Update: Aviram Declines Role, Hexter Continues. Lifeward Ltd. said that Rami Aviram will not take on the CFO position. Josh Hexter will remain the interim principal financial officer and principal accounting officer. The announcement keeps the company’s financial leadership stable while a permanent CFO is sought.
Transaction History
| NSPR | ▲ Buy | Grant | 226,695 | $0 | 1/14/2026 | View on chart |
| LFWD | ▲ Buy | Open Market | 2,000 | $10K | 5/23/2024 | View on chart |
| LFWD | ▲ Buy | Open Market | 5,000 | $3K | 8/25/2023 | View on chart |
| LFWD | ▲ Buy | Open Market | 5,000 | $3K | 8/25/2023 | View on chart |
| LFWD | ▲ Buy | Open Market | 5,000 | $3K | 8/25/2023 | View on chart |
| LFWD | ▲ Buy | Open Market | 51 | $31 | 8/23/2023 | View on chart |
| LFWD | ▲ Buy | Grant | 165,000 | $0 | 6/30/2023 | View on chart |
| LFWD | ▲ Buy | Grant | 225,000 | $0 | 9/19/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
InspireMD (NSPR) noted in pre‑market health‑care stock moves
NSPR was listed among twelve health‑care companies showing price action in Friday’s pre‑market session, according to Benzinga. The move comes while the stock’s RSI is low at 25.7 and it is near its $0.70 support level, suggesting continued pressure. Such activity may reflect renewed trader attention despite the broader market context.
InspireMD (NSPR) noted in pre‑market health‑care stock moves. NSPR was listed among twelve health‑care companies showing price action in Friday’s pre‑market session, according to Benzinga. The move comes while the stock’s RSI is low at 25.7 and it is near its $0.70 support level, suggesting continued pressure. Such activity may reflect renewed trader attention despite the broader market context.